Q4 2024 Earnings Call Transcript March 13, 2025 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is ...

Endo, Inc. (OTCQX: NDOI) revealed new insights from a post hoc data analysis of its Phase 3 clinical trial of XIAFLEX® ...

It is one thing to ignore the easily found evidence of the effectiveness of vaccination, but it is incredibly worse and ...

Artificial intelligence can transform medicine in a myriad of ways, including its promise to act as a trusted diagnostic aide ...

The combination of DeSci and AI could transform scientific research, challenging traditional funding, publishing and ...

Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant ...